About Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher
Clinical Trials at Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher
During the past decade, Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on
average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Eli Lilly and Company" with 3 trials
sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
Clinical Trials Conditions at Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher
According to Clinical.Site data, the most researched conditions in "Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher" are
"Juvenile Idiopathic Arthritis" (4 trials), "Rheumatoid Arthritis" (3 trials), "Arthritis, Psoriatic" (2 trials), "Active Juvenile Psoriatic Arthritis" (1 trials) and "Arthritis Juvenile Idiopathic" (1 trials). Many other conditions were trialed in "Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher" in a lesser frequency.
Clinical Trials Intervention Types at Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher
Most popular intervention types in "Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher" are "Drug" (19 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Baricitinib" (3 trials), "Guselkumab" (3 trials), "Nipocalimab" (2 trials) and "Tocilizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher
The vast majority of trials in "Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher" are
19 trials for "All" genders.
Clinical Trials Status at Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher
Currently, there are NaN active trials in "Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher".
undefined are not yet recruiting,
10 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher has several departments that took part in Clinical trials: "National Institute of Geriatrics" - 2 trials